Related Funds
Funds with similar focus
| Fund Name | Location |
| Adaptive Healthcare Fund | California, Los Angeles, United States |
| Bank Hapoalim | Israel, Tel Aviv, Tel Aviv District |
| Black Jays Investments | New York, New York, United States |
| Cedar Point Capital | Minnesota, Saint Louis Park, United States |
| Comway Capital | China, Shanghai |
| E Ink Holdings | Hsinchu, Taiwan, Taiwan Province |
| FA Holding | Bahrain, Capital Governorate, Manama |
| IITM Incubation Cell | Chennai, India, Tamil Nadu |
| Iridium Ventures | - |
| LATINIA | Barcelona, Catalonia, Spain |
| Milestone Partners | Pennsylvania, Radnor, United States |
| PureTech Health | Boston, Massachusetts, United States |
| Qingyan Lushi Investment | China, Guangdong, Tianjin |
| Spafinder Wellness | New York, New York, United States |
| Wentou Jianyuan Guanli Touzi | China, Shaanxi, Xianyang |
| Zhonghuicheng Touzi | China, Guangdong Province, Longgang District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Hopscotch Primary Care | $50M | 28 Jun 2024 | Chicago, Illinois, United States | ||
Hopscotch Primary Care | 01 Jan 2023 | Chicago, Illinois, United States | |||
Platelet BioGenesis | $75M | 04 Nov 2021 | Newton, Massachusetts, United States | ||
Click Therapeutics | $52M | 22 Oct 2021 | New York, New York, United States | ||
Cricket Health | $83M | 05 Aug 2021 | Boston, Massachusetts, United States | ||
Vesta Healthcare | $65M | 06 Apr 2021 | New York, New York, United States |
– Aptinyx Inc. has entered into a $50m loan facility and security agreement with K2 HealthVentures.
– The funds will provide general growth capital as Aptinyx advances its late-stage clinical pipeline of novel NMDA modulators.
– Under the terms of the agreement, the remaining $25m is subject to the achievement of certain terms and conditions, including regulatory and developmental milestones.
– Cricket Health from San Francisco is a provider of value-based kidney care.
– Company closed $83.5m Series B funding round.
– The round was led by Valtruis with participation from existing investors Oak HC/FT and Cigna Ventures, as well as K2 HealthVentures and a strategic investment from Blue Shield of California.
– The new investment will be used for rapid expansion to support demand for its care model for people with kidney disease across the United States.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Hopscotch Primary Care | $50M | 28 Jun 2024 | Chicago, Illinois, United States | ||
Hopscotch Primary Care | 01 Jan 2023 | Chicago, Illinois, United States | |||
Platelet BioGenesis | $75M | 04 Nov 2021 | Newton, Massachusetts, United States | ||
Click Therapeutics | $52M | 22 Oct 2021 | New York, New York, United States | ||
Cricket Health | $83M | 05 Aug 2021 | Boston, Massachusetts, United States | ||
Vesta Healthcare | $65M | 06 Apr 2021 | New York, New York, United States |
